Browse Category

US Stocks News 14 December 2025 - 24 December 2025

Top Stocks to Buy Today (Dec. 24, 2025): Nvidia, Amazon, Meta, Reddit, Rocket Lab and More as the S&P 500 Nears 7,000

Top Stocks to Buy Today (Dec. 24, 2025): Nvidia, Amazon, Meta, Reddit, Rocket Lab and More as the S&P 500 Nears 7,000

NEW YORK — U.S. stocks are heading into Christmas Eve trading with a familiar tailwind: big-tech strength, a fresh record close for the S&P 500, and renewed talk of a “Santa Claus rally” as markets head into the final stretch of 2025. The setup comes with one important wrinkle for investors: today is a shortened session, with the NYSE and…
Top Stocks to Buy Today: 10 Best U.S. Stock Picks for Dec. 18, 2025 (5:45 a.m. ET)

Top Stocks to Buy Today: 10 Best U.S. Stock Picks for Dec. 18, 2025 (5:45 a.m. ET)

U.S. stock investors are waking up to a market that suddenly feels a lot less “easy.” After Wednesday’s sharp pullback—driven largely by renewed anxiety over how the AI boom gets financed—today’s pre-market setup (Dec. 18, 2025) looks like a classic stock-picker’s tape: big sector dispersion, heavyweight tech volatility, energy strength tied to geopolitics, and a busy earnings slate that can…
Global Stock Market Today: AI-Led Tech Jitters Hit Asia, Europe Turns Cautious Before Central Banks, Micron Lifts U.S. Futures (Dec. 18, 2025)

Global Stock Market Today: AI-Led Tech Jitters Hit Asia, Europe Turns Cautious Before Central Banks, Micron Lifts U.S. Futures (Dec. 18, 2025)

Updated: 5:00 AM EST (10:00 GMT), Thursday, December 18, 2025 Global equities are starting December 18 on an uneasy footing, with investors reassessing the durability of the AI-fueled rally just as a dense run of central bank decisions and a closely watched U.S. inflation report approach. Overnight, a tech-heavy retreat in the U.S. reverberated across Asia, while early European trading…
Quantum Stocks on the US Market Today: IonQ, Rigetti, D‑Wave, QCi and Arqit Slide After Close as Analyst Coverage Expands (Dec. 17, 2025)

Quantum Stocks on the US Market Today: IonQ, Rigetti, D‑Wave, QCi and Arqit Slide After Close as Analyst Coverage Expands (Dec. 17, 2025)

NEW YORK — Wednesday, Dec. 17, 2025 (6:00 p.m. ET): Quantum-related stocks ended sharply lower after the U.S. market close, extending a choppy pullback that has rattled high-beta “future tech” themes in recent weeks. The selling came even as Wall Street broadened fresh analyst coverage of the sector and two of the most closely watched names released notable corporate updates tied to commercialization and scaling. …
Booking Holdings Inc. (BKNG) Stock: What to Know Before the US Market Opens on Dec. 15, 2025

Booking Holdings Inc. (BKNG) Stock: What to Know Before the US Market Opens on Dec. 15, 2025

Booking Holdings Inc. (NASDAQ: BKNG) heads into the Dec. 15 US session with investors balancing three big themes: resilient travel demand (especially as holiday season ramps), a clear push to widen margins through its Transformation Program, and a fast-evolving competitive landscape shaped by AI-driven travel discovery—particularly Google’s expansion of AI Mode into trip planning and, eventually, bookings. Q4 Capital Below…
PepsiCo Stock (PEP): What to Know Before the US Market Opens on Dec. 15, 2025

PepsiCo Stock (PEP): What to Know Before the US Market Opens on Dec. 15, 2025

PepsiCo, Inc. (NASDAQ: PEP) heads into Monday’s session (Dec. 15, 2025; US markets open 9:30 a.m. ET) with investors focused less on “headline growth” and more on whether the company can re-accelerate North America momentum—and do it without sacrificing margins. The near-term backdrop is dominated by one theme: shareholder activism turning into an operating playbook. In just the past two…
Eaton (ETN) Stock: Key News, Forecasts, and What to Watch Before the US Market Opens on Dec. 15, 2025

Eaton (ETN) Stock: Key News, Forecasts, and What to Watch Before the US Market Opens on Dec. 15, 2025

Updated: Sunday, Dec. 14, 2025 (ahead of Monday’s U.S. open) Eaton Corporation plc (NYSE: ETN) heads into the Dec. 15, 2025 session after a sharp Friday pullback that put the industrial power-management leader back in focus for both long-term investors and short-term traders. ETN closed at $331.98 on Friday, Dec. 12, down 5.25% on the day, with the session ranging…
Coherent Corp COHR Stock: What to Know Before the US Market Opens on Dec. 15, 2025

Coherent Corp COHR Stock: What to Know Before the US Market Opens on Dec. 15, 2025

Coherent Corp. stock (NYSE: COHR) heads into the Monday, Dec. 15, 2025 session after a sharp, high-volume selloff that put the spotlight on a single theme investors will likely keep trading around: share supply. On the last trading day before Monday’s open, COHR closed at $178.34, down 10.16% on the day, after swinging between roughly $176.30 and $198.60. Volume was…
Fiserv (FISV) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Fiserv (FISV) Stock: What to Know Before the U.S. Market Opens on Dec. 15, 2025

Fiserv’s stock heads into Monday’s U.S. session still trying to find a floor after one of the most dramatic resets among large-cap payments names in 2025. The company has spent the past six weeks navigating the aftershocks of a steep guidance cut, a leadership overhaul, and a wave of investor scrutiny—while also pointing to Clover as the business line with…
EV & Clean Energy Leaders: US Stocks Week Ahead (Dec. 15–19, 2025) — Tesla, Rivian, NextEra, Solar and Grid Tech in Focus

EV & Clean Energy Leaders: US Stocks Week Ahead (Dec. 15–19, 2025) — Tesla, Rivian, NextEra, Solar and Grid Tech in Focus

Updated: December 14, 2025 US-listed EV and clean energy leaders enter the new week with a rare mix of tailwinds and tripwires: a fresh Federal Reserve rate cut that should support long-duration growth stocks, a catch-up “data deluge” after the fall government shutdown, and a policy backdrop that’s now the single biggest swing factor for renewables and EV demand. The…
Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Healthcare & Pharma Giants US Stocks: Week Ahead Outlook After Eli Lilly’s Retatrutide, CVS Guidance, Pfizer’s Obesity Deal, and J&J’s Talc Verdict (Updated Dec. 14, 2025)

Updated: December 14, 2025Coverage window for this report: December 8–14, 2025 Wall Street heads into the week of Dec. 15, 2025 with U.S. healthcare and pharma mega-caps back in the spotlight—pulled by three powerful forces that all intensified in the last seven days: (1) the obesity-drug arms race, (2) Washington’s policy crosscurrents around insurance subsidies and PBM transparency, and (3)…
Energy Supermajors US Stocks Week Ahead: Exxon, Chevron, Shell, BP and TotalEnergies Brace for 2026 “Oil Glut” Narratives (Updated Dec. 14, 2025)

Energy Supermajors US Stocks Week Ahead: Exxon, Chevron, Shell, BP and TotalEnergies Brace for 2026 “Oil Glut” Narratives (Updated Dec. 14, 2025)

Energy supermajors enter the new week with investors torn between two powerful forces: near-term “oversupply” pressure in crude and a steady drumbeat of company-specific catalysts—strategy resets, offshore deal-making, and portfolio moves that can matter as much as oil itself. As U.S. markets reopen on Monday, Dec. 15, the main U.S.-listed supermajors are coming off a choppy commodity week: Exxon Mobil…
1 2 3

Stock Market Today

  • Kering (ENXTPA:KER) Valuation Check After Share-Price Weakness and Mixed Returns
    January 17, 2026, 10:24 AM EST. Kering (ENXTPA:KER) has faced renewed pressure as shares weaken. The luxury group's stock slid 4.21% in the latest session, with momentum fading over the past week, month and three months, though the 1-year total return remains positive at 22.07%. The valuation shows a P/E around 48.6x, near peers at about 53.8x. The market implies a Fair Value of €296.45 versus a last close of €288.70, a small gap. Analysts' targets range from €135.0 to €360.0, with a consensus near €200.65. Risks include revenue declines across key brands and ongoing store closures, which could pressure margins. A roughly 2.6% undervaluation signal persists, modest in the face of the earnings multiple.
Go toTop